Global /Germany /Healthcare /Biotechnology /BNN
chevron_leftBack
BRAIN Biotech AG logo

BRAIN Biotech AG

BNN
XETRA: BNN Delayed
2.76EUR 3.4%
3.21 USD
As of 5 June 2026, BRAIN Biotech AG has a market cap of $67.66M USD, ranking #28349 globally and #299 in Germany. It ranks #2570 in the Healthcare sector, and #498 in the Biotechnology industry.
Global Rank
28349
Country Rank
299
Sector Rank
2570
Industry Rank
498
Key Stats
Market Cap
$67.66MUSD
58.33M EUR
Enterprise Value
$61.78MUSD
53.19M EUR
Revenue (TTM)
$56.84MUSD
49.01M EUR
EBITDA (TTM)
-$4.15MUSD
-3.57M EUR
Net Income (TTM)
-$12.32MUSD
-10.62M EUR
EBITDA Margin
-7.3%
Profit Margin
-22%
PS Ratio
1.2
PB Ratio
-80.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Adriaan Moelker open_in_new
Employees
292
Founded
1993
Website
brain-biotech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.4% 5.5% 13% 15% 24% 15%

News

Loading...

Markets

Exchange Ticker Price
Deutsche Börse Xetra
MIC: XETR
PRIMARY
BNN
ISIN: DE0005203947
Shares Out.:
21.848M1 Shares Float: 10.443M2
TV:
SA:
YF:
GF:
BA:
BNN
MS:
2.76 EUR
London Stock Exchange
MIC: XLON
0RFI
ISIN: DE0005203947
TV:
SA:
YF:
GF:
BA:
MS:
2.55 EUR
Frankfurt Stock Exchange
MIC: XFRA
BNN
ISIN: DE0005203947
TV:
SA:
YF:
GF:
BA:
BNN
MS:
2.76 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Similar Companies

Industry: Biotechnology (Germany)
Name
Market Cap diff.
PE
BNTX
$25.69B
38K%
-
$1.69B
1.46B EUR
2K%
-
CVAC
$1.04B
1K%
5.0
IFRX
$143.14M
112%
-
7V0
$107.17M
92.4M EUR
58%
5.0
V3V
$89.36M
77.05M EUR
32%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
270K%
23.9
GILD
$159.92B
236K%
19.0
ARGX
$48.01B
41.39B EUR
71K%
39.9
$44.36B
68.19T KRW
65K%
35.5
CSL
$42.98B
60.27B AUD
63K%
29.3
LONN
$42.55B
33.71B CHF
63K%
37.2
chevron_leftBack